In this study, we analyzed the significance of γ-H2AX and 53BP1 foci in nuclei of PBMCs as potential diagnostic and disease activity markers for CIS/early RRMS using immunocytochemistry combined with fully automated immunofluorescence microscopy. Here, TP53BP1 is linked to in situ carcinoma.